CG
AVNS

Caprock Group’s Avanos Medical AVNS Stock Holding History

Caprock Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,307
Closed -$227K – 364
2018
Q3 		$227K Buy
+3,307
New +$213K 0.05% 332
2018
Q1 		– Sell
-11,062
Closed -$546K – 451
2017
Q4 		$546K Hold
11,062
– – 0.11% 190
2017
Q3 		$498K Hold
11,062
– – 0.1% 188
2017
Q2 		$435K Buy
11,062
+3
+0% +$113 0.1% 199
2017
Q1 		$421K Sell
11,059
-1,047
-9% -$40.8K 0.1% 182
2016
Q4 		$448K Hold
12,106
– – 0.11% 166
2016
Q3 		$420K Buy
+12,106
New +$424K 0.1% 200

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Caprock Group's AVNS Position: Q4 2018 in Review

Caprock Group sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 3,307 shares — an estimated $227K sold.

Caprock Group first reported a position in AVNS in Q3 2016 and held it in 7 quarters. The position peaked at $546K in Q4 2017. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • Caprock Group reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • Caprock Group sold 3,307 Avanos Medical shares in Q4 2018, an estimated $227K.
  • Caprock Group first reported a position in Avanos Medical in Q3 2016 and held it in 7 quarters.
  • Caprock Group's Avanos Medical position peaked at $546K in Q4 2017.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Caprock Group's 13F filing for Q4 2018, filed 29 Jan 2019.